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WS19.1 Mediastinal lymphadenopathy: A prognostic tool in adult
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G. Pizzamiglio2. 1Universita` degli Studi di Milano, IRCCS Fondazione Ca`
Granda, Ospedale Maggiore Policlinico Milano, Dipartimento di Fisiopatologia
Medico-Chirurgica e dei Trapianti, Milan, Italy; 2Fondazione Ca` Granda,
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Objectives: Mediastinal lymph node progression and its implications on lung
function of cystic ﬁbrosis patients are not extensively described. The present study
analyzes these aspects in an adult population.
Methods: The presence of lymphadenopathy and the lung functional indices were
retrospectively recorded in patients who underwent chest CT scan, for usual disease
progression control. The same indices were recorded again in patients for whom
chest CT scan was repeated.
Results: A total of 154 patients underwent a chest CT: 83 (38%) patients showed
mediastinal lymphadenopathy. A second chest CT scan was performed for 80
individuals out of 154: 61 (76%) had lymphadenopathy (42 conﬁrmed previous
ﬁnding; 19 new cases; 6 turned negative).
No difference in lung function data was observed in patients with and without lymph
nodes at the time of the ﬁrst CT: FEV1 = 68% IQR 47.5–85.5% vs. 64% IQR 53.5–
83.0 p = 0.94; FVC = 80.7% IQR 67.5−95% Vs 83% IQR 72.5–91.0%, p = 0.89. At
follow up, values of FVC% were signiﬁcantly lower in patients with lymph nodes
at the ﬁrst CT: 71.0% IQR 55.25–88.75% vs 84.0% IQR 80.0–100.5%, p = 0.035.
The annual lung function decline was greater for patients with lymphadenopathy in
comparison with patients without this ﬁnding; FVC: −3.28% (IQR −5.25, −1.24) vs.
−0.33% (IQR −2.7, −1.62) p = 0.006; FEV1: −2.8% (IQR −4.5; −2.8) vs. −1.29%
(IQR −2.57, 0.48) p = 0.02.
Conclusion: Mediastinal lymphadenopathy becomes more frequent as the disease
progresses and it is associated with at a more rapid functional decline; this ﬁnding
might be an useful tool in the research of a prognostic score in the adult patients
with cystic ﬁbrosis.
WS19.2 Sinus pathogens in children with cystic ﬁbrosis: Do they
relate to lower respiratory tract pathogens and is eradication
successful?
P. Wilson1, C. Lambert1, S.B. Carr1, C. Pao1. 1The Royal London Childrens Hospital,
Paediatric Cystic Fibrosis, London, United Kingdom
Paranasal sinuses are an ideal environment for bacterial growth, and may create
colonisation leading to lower respiratory tract (LRT) infections.
Objectives:
• To look for correlation between sinus and lung pathogens in children with CF
• To test a new protocol for eradication of paranasal sinus pathogens.
Method: Paired sinus and LRT samples were taken from children using sinus rinses.
Protocolised antibiotic treatment was prescribed following positive cultures. Existing
treatment protocols were modiﬁed for oral +/− nasal nebulised antibiotics. Repeat
washouts were taken following treatment.
Results: 117 patients attended; 42 too young, 21 declined, 41 patients sampled.
Table: Correlation of paired timed sinus and LRT samples








Pseudomonas aeruginosa 4 2 1 0
Staphylococcus aureus 0 1 0 0
Other (including MRSA) 1 0 2a 1
None 3 4 4 18
aNot same pathogen in LRT to sinus.
11 with negative LRT had positive sinus cultures. Only 1 negative sinus had a positive
LRT sample. All patients received treatment for positive LRT samples. Sinus treatment
was provided to 11/22 patients; 5/7 to date have had successful eradication. The
remaining patients did not receive treatment due to chronic colonisation.
Conclusion: 23 paired timed sinus and LRT samples showed a correlation. Eradication
from sinus was successful in 72% of samples to date, however 4 patients have isolated
different pathogens on repeat sinus rinses. There were 11 patients who grew pathogens
in their sinus with no evidence of pathogens in their LRT. Long term follow up is
required to prevent LRT acquisition and colonisation in this group.
WS19.3 The value of deep oropharyngeal suction specimens in
identifying lower airway bacteria in young children with
cystic ﬁbrosis
M. Doumit1, Y. Belessis2,3 , S. Stelzer-Braid4,5 , W.D. Rawlinson5,6, A. Jaffe3. 1Sydney Children’s
Hospital, Physiotherapy, Randwick, Australia; 2Sydney Children’s Hospital, Respiratory Medicine,
Randwick, Australia; 3University of New South Wales, School of Women’s and Children’s Health,
Sydney, Australia; 4University of New South Wales, School of Medical Sciences, Sydney, Australia;
5SEALS Microbiology, Prince of Wales Hospital, Virology Division, Sydney, Australia; 6University
of New South Wales, Sydney, Australia
Objectives:
1. To compare bacterial isolates from upper airway samples obtained via deep oropharyngeal suction
(OPS) with broncho-alveolar lavage (BAL) in young children with CF.
2. Assess level of child distress during OPS.
Methods: Young children with CF undergoing BAL as part of an annual surveillance program were
studied. OPS was performed by stimulating a cough and suctioning the back of the oropharynx with
the child awake to mimic clinical practice. BAL of the right upper, middle and lingula lobes was
then performed. Child distress during OPS was rated using the Groningen Distress Scale (1 =Calm,
2 =Timid/Nervous, 3 = serious distress but still under control, 4 = serious distress with loss of control,
5 = panic).
Results: Paired OPS and BAL samples were obtained in 58 children (32 boys, mean age 36 months).
Isolation of any growth was considered a positive culture. Table 1 shows diagnostic accuracy of OPS
compared to BAL. Table 2 displays levels of distress.















Pseudomonas aeruginosa, n (%) 3 (5) 67% (21−94) 96% (88−99) 50% (8−92) 98% (90–100)
Staphylococcus aureus, n (%) 11 (19) 82% (52−95) 87% (75−94) 60% (32−84) 95% (84−99)
Haemophilus inﬂuenzae, n (%) 25 (43) 40% (23−59) 88% (73−95) 71% (42−91) 66% (50−80)
Aspergillus fumigatus, n (%) 11 (19) 36% (15−65) 98% (89–100) 80% (29−97) 87% (75−95)
Stenotrophomonas maltophilia, n (%) 4 (7) 0% (0−49) 96% (87−99) 0% (0−81) 93% (83−98)
MRSA, n (%) 2 (3) 50% (9−91) 100% (94–100) 100% (17–100) 98% (91–100)















1 [1−1] 3 [2−3] 4 [3−4] 4 [3−4.5] 2.5 [2−3.5] 2 [2−2]
Conclusion: A negative OPS result is a good indicator of the absence of lower airway infection,
except for haemophilus inﬂuenza. However, a positive OPS result is not a good predictor of lower
airway infection. Distress during OPS was age related and peaked from 24−48 months.
WS19.4 A randomised controlled trial of the effect of hypertonic
saline (HS) inhalation on exacerbation resolution, hospital
length of stay and time to relapse in adults with cystic
ﬁbrosis
R. Dentice1,2, M. Elkins1, P. Middleton3, J. Bishop3, P. Wark4, D. Dorahy4,
C. Harmer2, P. Bye1, HSHS Study Group. 1Royal Prince Alfred Hospital,
Respiratory Medicine, Sydney, Australia; 2University of Sydney, Sydney, Australia;
3Westmead Hospital, Sydney, Australia; 4John Hunter Hospital, Sydney, Australia
Objective: To determine the effects of HS during hospitalisation for CF pulmonary
exacerbation on length of stay, lung function, oxygenation, bacterial load, symptom
scores, quality of life, exercise tolerance, and time to relapse.
Methods: 132 adults, mean age 28 (SD 9) y, FEV1 48 (20) %pred, were randomised
to thrice-daily nebulisation of 4mL of 7% saline or a taste-masked control of 0.12%
saline throughout their hospital admission.
Results: All participants tolerated their allocated inhalation solution. Length of stay
was 12 days in the HS group and 13 days in the control group (MD 1 day, 95%CI 0
to 2). Exacerbations (as deﬁned by Fuchs 1994) resolved on day 10 in the HS group
and day 11 in the control group (MD 1 day, 0 to 2). Participants were signiﬁcantly
more likely to return to their baseline FEV1 at discharge in the HS group (75%)
than the control group (57%), NNT 6 (3 to 65). On a 100-mm visual analogue scale
recorded daily, the HS group had signiﬁcantly greater improvement than the control
group in: sleep disturbance by 15mm (95%CI 6 to 23), chest congestion (9mm, 4
to 14), and dyspnoea (6mm, 1 to 12); and borderline signiﬁcance for fatigue (8mm,
0 to 15) and cough (6mm, 0 to 11). At discharge, the HS group had signiﬁcantly
less severe: sleep disturbance by 13mm (95%CI 4 to 23), chest congestion (10mm,
3 to 18), and dyspnoea (8mm, 1 to 16). After 12 months followup, no signiﬁcant
difference in time to next exacerbation requiring hospitalisation has been detected
between groups (p = 0.3).
Conclusion: For a similar or shorter length of stay in hospital, nebulised HS allows
patients to leave hospital with greater resolution of their exacerbation.
